Healthcare provider profile · identity verified

Mark J. Cooper, M.D.

Family Practice · CRESTVIEW, FL · NPI 1063481182

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	583	160
Levothyroxine Sodium	Levothyroxine Sodium	487	113
Losartan Potassium	Losartan Potassium	428	105
Amlodipine Besylate	Amlodipine Besylate	379	93
Rosuvastatin Calcium	Rosuvastatin Calcium	377	104
Omeprazole	Omeprazole	332	84
Lisinopril	Lisinopril	310	81
Metformin Hcl	Metformin Hcl	302	87
Gabapentin	Gabapentin	236	69
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	222	24
Alprazolam	Alprazolam	212	35
Metoprolol Succinate	Metoprolol Succinate	203	52
Tramadol Hcl	Tramadol Hcl	202	31
Albuterol Sulfate Hfa	Albuterol Sulfate	197	50
Trazodone Hcl	Trazodone Hcl	185	43
Duloxetine Hcl	Duloxetine Hcl	164	30
Hydrochlorothiazide	Hydrochlorothiazide	164	42
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	150	19
Tamsulosin Hcl	Tamsulosin Hcl	141	33
Zolpidem Tartrate	Zolpidem Tartrate	140	22
Sertraline Hcl	Sertraline Hcl	139	38
Furosemide	Furosemide	134	39
Pantoprazole Sodium	Pantoprazole Sodium	131	32
Simvastatin	Simvastatin	126	33
Oxycodone Hcl	Oxycodone Hcl	125	11
Trulicity	Dulaglutide	124	26
Potassium Chloride	Potassium Chloride	122	30
Eliquis	Apixaban	116	21
Escitalopram Oxalate	Escitalopram Oxalate	103	26
Clonazepam	Clonazepam	98	15
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	98	24
Carvedilol	Carvedilol	97	24
Metoprolol Tartrate	Metoprolol Tartrate	96	21
Fluticasone Propionate	Fluticasone Propionate	94	31
Glimepiride	Glimepiride	88	26
Montelukast Sodium	Montelukast Sodium	88	20
Allopurinol	Allopurinol	83	24
Pravastatin Sodium	Pravastatin Sodium	81	23
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	76	16
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	74	18
Ezetimibe	Ezetimibe	70	18
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	70	19
Meloxicam	Meloxicam	69	16
Fluoxetine Hcl	Fluoxetine Hcl	66	14
Pregabalin	Pregabalin	65	13
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	63	15
Mounjaro	Tirzepatide	61	12
Fenofibrate	Fenofibrate	59	11
Clopidogrel	Clopidogrel Bisulfate	58	16
Esomeprazole Magnesium	Esomeprazole Magnesium	56	suppressed
Famotidine	Famotidine	56	17
Aripiprazole	Aripiprazole	55	suppressed
Atenolol	Atenolol	52	11
Ropinirole Hcl	Ropinirole Hcl	52	12
Bupropion Xl	Bupropion Hcl	46	suppressed
Diazepam	Diazepam	45	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	44	12
Buspirone Hcl	Buspirone Hcl	42	12
Celecoxib	Celecoxib	42	11
Tizanidine Hcl	Tizanidine Hcl	40	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	38	suppressed
Mirtazapine	Mirtazapine	37	suppressed
Morphine Sulfate Er	Morphine Sulfate	36	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	35	12
Valacyclovir	Valacyclovir Hcl	34	12
Alendronate Sodium	Alendronate Sodium	33	13
Chlorthalidone	Chlorthalidone	33	suppressed
Eszopiclone	Eszopiclone	33	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	33	suppressed
Fluconazole	Fluconazole	32	13
Jardiance	Empagliflozin	32	suppressed
Ozempic	Semaglutide	31	11
Hydralazine Hcl	Hydralazine Hcl	30	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	29	12
Metformin Hcl Er	Metformin Hcl	29	suppressed
Rizatriptan	Rizatriptan Benzoate	28	suppressed
Breo Ellipta	Fluticasone/Vilanterol	26	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	26	suppressed
Symbicort	Budesonide/Formoterol Fumarate	26	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	26	12
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	25	suppressed
Clonidine Hcl	Clonidine Hcl	25	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	25	suppressed
Diltiazem Hcl	Diltiazem Hcl	25	suppressed
Nystatin	Nystatin	25	11
Promethazine Hcl	Promethazine Hcl	25	suppressed
Amoxicillin	Amoxicillin	24	12
Citalopram Hbr	Citalopram Hydrobromide	24	suppressed
Lorazepam	Lorazepam	24	suppressed
Tresiba Flextouch U-200	Insulin Degludec	24	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	24	suppressed
Benazepril Hcl	Benazepril Hcl	23	suppressed
Donepezil Hcl	Donepezil Hcl	23	suppressed
Estradiol	Estradiol	23	suppressed
Januvia	Sitagliptin Phosphate	23	suppressed
Synthroid	Levothyroxine Sodium	23	suppressed
Prednisone	Prednisone	22	14
Tolterodine Tartrate Er	Tolterodine Tartrate	22	suppressed
Diclofenac Sodium	Diclofenac Sodium	21	suppressed
Glipizide	Glipizide	21	suppressed
Lovastatin	Lovastatin	21	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	21	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	21	16
Pioglitazone Hcl	Pioglitazone Hcl	21	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	21	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	21	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	20	suppressed
Finasteride	Finasteride	20	suppressed
Ibuprofen	Ibuprofen	20	suppressed
Ondansetron Odt	Ondansetron	20	suppressed
Valsartan	Valsartan	20	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	19	13
Ondansetron Hcl	Ondansetron Hcl	19	suppressed
Warfarin Sodium	Warfarin Sodium	19	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	18	suppressed
Farxiga	Dapagliflozin Propanediol	18	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	17	14
Dropsafe Prep Pads	Alcohol Antiseptic Pads	17	suppressed
Ibandronate Sodium	Ibandronate Sodium	17	suppressed
Novolog Flexpen	Insulin Aspart	17	suppressed
Spironolactone	Spironolactone	17	suppressed
Sucralfate	Sucralfate	17	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	17	suppressed
Azithromycin	Azithromycin	16	14
Clobetasol Propionate	Clobetasol Propionate	16	suppressed
Temazepam	Temazepam	16	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	14	suppressed
Baclofen	Baclofen	14	suppressed
Linzess	Linaclotide	14	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	13	suppressed
Meclizine Hcl	Meclizine Hcl	13	suppressed
Topiramate	Topiramate	13	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	13	suppressed
Clonidine	Clonidine	12	suppressed
Felodipine Er	Felodipine	12	suppressed
Irbesartan	Irbesartan	12	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	12	suppressed
Naproxen	Naproxen	12	suppressed
Primidone	Primidone	12	suppressed
Propranolol Hcl	Propranolol Hcl	12	suppressed
Testosterone Cypionate	Testosterone Cypionate	12	suppressed
Tramadol Hcl Er	Tramadol Hcl	12	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	11	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	11	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	11	suppressed
Atrovent Hfa	Ipratropium Bromide	11	suppressed
Azelastine Hcl	Azelastine Hcl	11	suppressed
Boostrix Tdap	Diphth,pertuss(Acell),tet Vac	11	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	11	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	11	suppressed
Rivastigmine	Rivastigmine Tartrate	11	suppressed
Sildenafil Citrate	Sildenafil Citrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error